RBC Capital Markets – February 24
BTIG – February 25
Barclays – March 16
Credit Suisse – March 16
SOUTH JORDAN, Utah, Feb. 10, 2016 -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, today announced that it will present at four investor conferences in the next few weeks.
On Wednesday, February 24, at 10:30 a.m. ET, Merit’s Chairman and Chief Executive Officer Fred P. Lampropoulos will present and participate in one-on-one meetings at the RBC Capital Markets Healthcare Conference at The New York Palace Hotel in New York City.
On Thursday, February 25, Merit’s Chief Financial Officer Bernard Birkett will participate in one-on-one meetings at BTIG’s Snowbird MedTech Conference in Snowbird, Utah.
On Wednesday, March 16, at 9:30 a.m. ET, Lampropoulos will present and participate in one-on-one meetings at Barclays Global Healthcare Conference at Loews Miami Beach Hotel in Miami Beach, Florida.
On Wednesday, March 16, Birkett will participate in one-on-one meetings at the Credit Suisse Under Followed Opportunities (UFO) Conference at the Credit Suisse offices in Boston.
ABOUT MERIT
Founded in 1987, Merit Medical Systems, Inc. is engaged in the development, manufacture and distribution of proprietary disposable medical devices used in interventional and diagnostic procedures, particularly in cardiology, radiology and endoscopy. Merit serves client hospitals worldwide with a domestic and international sales force totaling approximately 200 individuals. Merit employs approximately 3,700 people worldwide with facilities in South Jordan, Utah; Pearland, Texas; Richmond, Virginia; Malvern, Pennsylvania; Maastricht and Venlo, The Netherlands; Paris, France; Galway, Ireland; Beijing, China; Tijuana, Mexico; and Rockland, Massachusetts.
Contact: Anne-Marie Wright, Vice President, Corporate Communications Phone: (801) 208-4167 e-mail: [email protected] Fax: (801) 253-1688


Novartis Q1 2026 Earnings Miss Expectations as Generic Competition Pressures Sales
China’s Ultra-Cheap EV Boom: Why Electric Cars Cost Far Less Than in the U.S.
AstraZeneca Q1 2026 Earnings Surge on Strong Oncology and Rare Disease Drug Sales
Advantest Stock Falls on Weak Outlook Despite Strong AI-Driven Results
Lightelligence IPO Soars Over 400% in Hong Kong Debut Amid Rising AI Investment Demand
Australia Targets Meta, Google, and TikTok With New News Payment Tax Proposal
Why Paycom Was Named a 2026 Platinum Employer on the Where You Work Matters List
Spirit Airlines Gains Key Creditor Support for $500M Bailout Deal
TSMC Exits Arm Holdings with $231 Million Share Sale Amid Strategic Portfolio Shift
Brazil Pension Fund Crackdown After Banco Master Collapse Raises Investment Concerns
Robinhood Q1 Earnings Miss Expectations, Stock Drops After Hours
Air Liquide Q1 Revenue Misses Estimates Amid Currency and Energy Headwinds
OpenAI Faces Revenue Pressure and User Growth Challenges Ahead of IPO
Toyota Global Vehicle Sales Decline in March Amid RAV4 Transition and Middle East Slowdown
SMC Corp Stock Surges as Palliser Capital Pushes for Major Share Buyback
U.S. Demand for Alternative Satellite Providers Remains Strong Amid SpaceX Regulatory Push
Chinese Chip Stocks Surge on AI Boom and Domestic Tech Push 



